Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients
International Journal of Molecular Sciences · 15.12.2023 · 24 (24) · 17518
DOI: 10.3390/ijms242417518 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.12.2023. Verfasst von Ulrich Räth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Hauptthemen laut MEDLINE: Critical Illness, Sepsis, Tumor Necrosis Factor Receptor Superfamily, Member 9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
T cell depletion and functional impairment are characteristics of sepsis. CD137 is a costimulatory receptor on activated T cells, while soluble CD137 (sCD137) inhibits CD137 signaling. This study found elevated sCD137 levels in the plasma of patients with systemic inflammatory response syndrome (SIRS), sepsis, or septic shock compared to healthy controls. The sCD137 levels negatively correlated with the C-reactive protein and positively with procalcitonin and interleukin-6. There was no difference in sCD137 levels based on ventilation, dialysis, or vasopressor treatment. Patients with SARS-CoV-2, Gram-positive, or Gram-negative bacterial infections had similar sCD137 levels as noninfected individuals. Notably, higher plasma sCD137 levels were observed in non-survivors compared to survivors in both the SIRS/sepsis group and the SARS-CoV-2 subgroup. In conclusion, plasma sCD137 levels are associated with severe illness and survival in critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
- Department of Physiology, and Immunology Programme, Yong Loo Lin School of Medicine, National University of Singapore, MD9, Singapore 117597, Singapore.
ORCID-Profile: Herbert Schwarz, Stephan Schmid, Christa Buechler, Vlad Pavel
Zitieren
APA
Räth, U., Mester, P., Schwarz, H., Schmid, S., Müller, M., Buechler, C., & Pavel, V. (2023). Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients. International Journal of Molecular Sciences, 24(24), 17518. https://doi.org/10.3390/ijms242417518
Vancouver
Räth U, Mester P, Schwarz H, Schmid S, Müller M, Buechler C, et al. Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients. International Journal of Molecular Sciences. 2023;24(24):17518. doi:10.3390/ijms242417518
BibTeX
@article{Rth2023,
author = {Räth, Ulrich and Mester, Patricia and Schwarz, Herbert and Schmid, Stephan and Müller, Martina and Buechler, Christa and Pavel, Vlad},
title = {Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {24},
pages = {17518},
doi = {10.3390/ijms242417518}
}
EUVIMED